• Mashup Score: 0

    This retrospective observational study was conducted across 24 Multicenter Perioperative Outcomes Group institutions in the United States with sugammadex on formulary at the time of the study. All American Society of Anesthesiologists (ASA) physical status I–IV adults undergoing noncardiac surgery from 2014 to 2018 receiving neuromuscular blockade (NMB) were eligible. The study established 3…

    Tweet Tweets with this article
    • 🔴 Based on data from the Multicenter Perioperative Outcomes Group, in the US, #sugammadex is preferentially used for patients with more comorbiditities and known risk factors for residual blockade or pulmonary cx #NMB #Reversal #MPOG #anesthesiology https://t.co/jTSMFN4tJp https://t.co/4mCZtifLKk

  • Mashup Score: 3

    Objective: The purpose of this study was to evaluate the safety and efficacy of sugammadex for fast-track surgery in children undergoing cardiac surgery.Design: This was a prospective, randomized, controlled clinical study.Setting: University hospital.Participants: The study comprised 60 children undergoing cardiac surgery.Interventions: The children in group S received sugammadex, 4 mg/kg, for…

    Tweet Tweets with this article
    • #Sugammadex can shorten the extubation time & reduce incidence of postoperative atelectasis, with fewer adverse events, in children undergoing cardiac #surgery. Beneficial to use sugammadex for fast-track surgery in children undergoing cardiac surgery. https://t.co/OyI62khicC https://t.co/zxMWrZEh68

  • Mashup Score: 0

    As you were browsing www.anesthesiologynews.com something about your browser made us think you were a bot. There are a few reasons this might happen: You’re a power user moving through this website with super-human speed. You’ve disabled JavaScript in your web browser. A third-party browser plugin,…

    Tweet Tweets with this article
    • A recent trial found no incidence of #reintubation due to residual #neuromuscular blockade within 48 hours of #sugammadex administration. https://t.co/DN9qbTsCOu @_DoctorDoug @PittCCM #anesthesia #ESRD

  • Mashup Score: 2

    As you were browsing www.anesthesiologynews.com something about your browser made us think you were a bot. There are a few reasons this might happen: You’re a power user moving through this website with super-human speed. You’ve disabled JavaScript in your web browser. A third-party browser plugin,…

    Tweet Tweets with this article
    • Lower doses of #sugammadex may not result in clinically significant delays in recovery from #neuromuscular blockade. https://t.co/SOHOuJ4LbH

  • Mashup Score: 2

    As you were browsing www.anesthesiologynews.com something about your browser made us think you were a bot. There are a few reasons this might happen: You’re a power user moving through this website with super-human speed. You’ve disabled JavaScript in your web browser. A third-party browser plugin,…

    Tweet Tweets with this article
    • Lower doses of #sugammadex may not result in clinically significant delays in recovery from #neuromuscular blockade. https://t.co/SOHOuJ4LbH

  • Mashup Score: 1

    As you were browsing www.anesthesiologynews.com something about your browser made us think you were a bot. There are a few reasons this might happen: You’re a power user moving through this website with super-human speed. You’ve disabled JavaScript in your web browser. A third-party browser plugin,…

    Tweet Tweets with this article
    • New study: Neuromuscular block protocol associated with low incidence of postoperative residual neuromuscular blockade. https://t.co/NUBZvclU8Q @UW #rocuronium #neostigmine #sugammadex #medtwitter

  • Mashup Score: 6

    As you were browsing www.anesthesiologynews.com something about your browser made us think you were a bot. There are a few reasons this might happen: You’re a power user moving through this website with super-human speed. You’ve disabled JavaScript in your web browser. A third-party browser plugin, such as Ghostery or …

    Tweet Tweets with this article
    • Residual #Blockade Tested Following Reversal With #Sugammadex or #Neostigmine @OHSUanesthesia https://t.co/voUD4MWKS6

  • Mashup Score: 1

    s retrospective observational study was conducted across 24 Multicenter Perioperative Outcomes Group institutions in the United States with sugammadex on formulary at the time of the study. All American Society of Anesthesiologists (ASA) physical status I–IV adults undergoing noncardiac surgery from 2014 to 2018 receiving neuromuscular blockade (NMB) were eligible. The study established 3 periods…

    Tweet Tweets with this article
    • PAP Based on data from the Multicenter Perioperative Outcomes Group, in the US, #sugammadex is preferentially used for patients with more comorbidities and known risk factors for residual blockade or pulmonary cx https://t.co/XVlHmxHcvM https://t.co/B2IUsAV5Hz